The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Discontinuation of imatinib in patients with oligo-metastatic gastrointestinal stromal tumor who are in complete radiological remission: A prospective multicenter phase II study.
 
Ivar Hompland
No Relationships to Disclose
 
Kjetil Boye
Consulting or Advisory Role - Bayer
Research Funding - Bayer (Inst); Deciphera (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst)
 
Andri Papakonstantinou
No Relationships to Disclose
 
Bård Røsok
No Relationships to Disclose
 
Heikki Joensuu
Employment - Orion
Stock and Other Ownership Interests - Orion; Sartar Therapeutics
Honoraria - Deciphera; Neutron Therapeutics
Consulting or Advisory Role - Neutron Therapeutics; Orion
Patents, Royalties, Other Intellectual Property - Sartar Therapeutics
 
Øyvind Bruland
No Relationships to Disclose